AzTrials
AzTrials

Diet, HealthyNCT05377892

The Impact of Dietary Protein on the Metabolome

A study testing Dietary protein in people with Diet, Healthy, run by Stony Brook University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is known that tumors have an affinity for taking up amino acids from circulation or nearby tissues to use as a fuel source, to enhance their growth. Work in rodents has shown that when the levels of amino acids are reduced in diet, tumor growth is slowed and tumors are more susceptible to anti-cancer therapies. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Diet, Healthy
What is being tested?
Dietary protein
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteUnited States
Study dates
4 Nov 2019to 5 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-30 years
  • BMI 18-29.9

Who cannot join

  • Those with a history of significant illness including diabetes, renal, liver or cardiovascular disease, malnutrition, GI disease (including IBS, IBD, chronic constipation or diarrhea), mental illness (i.e. depression, bipolar disorder)
  • Those adhering to a vegetarian or vegan diet.
  • Those having taken antibiotics within 1 month of starting the study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stony Brook University

    Stony Brook, New York, 11794

Other trials in United States

About this study

Official title: Modulating Dietary Protein to Alter Circulating and Gut Metabolites

It is known that tumors have an affinity for taking up amino acids from circulation or nearby tissues to use as a fuel source, to enhance their growth. Work in rodents has shown that when the levels of amino acids are reduced in diet, tumor growth is slowed and tumors are more susceptible to anti-cancer therapies. There are limited evidence-based dietary recommendations for cancer patients, which represents an urgent and unmet need. It is likely that reducing dietary protein will be beneficial, however this has not been tested. In advance of carrying out a study in cancer patients a study in healthy volunteers needs to be conducted to determine whether altering the amount of dietary protein, impacts the levels of amino acids (or other metabolites) in blood or the intestine. By demonstrating that altering dietary protein can alter the metabolome of healthy individuals, it will provide the information needed to reduce protein intake in cancer patients in future studies.

Read the detailed description

After providing consent, subjects will undergo an indirect calorimetry test, which involves breathing through a disposable, single-use mouth piece into a machine that estimates calorie needs based on oxygen consumed and CO2 produced. Then subjects will be instructed on how to keep a 3-day food record and complete the Qualtrics survey designed for this purpose within 2 weeks of consenting. Nutrient content of the participants' typical diet will be calculated, based on the 3-day and Qualtrics-based food/beverage log, using Food Processor software. Meals for the acclimation period will be created to mimic the participants' typical diet (daily calories and percent of calories from carbohydrate, protein and fat), as well as to meet their calorie needs per the indirect calorimeter test, for the first 7-9 days of the study. High protein diets (2g of protein/kg/day) will then be devised and provided for the next 14-16 days. Following this period, reduced protein diets (0.8g of protein/kg/day) will be devised and provided for the next 14-16 days. Fat content will be modulated to keep diets isocaloric while keeping carbohydrate content stable. Participants will choose between two 3-day cycle menus for each feeding phase. Meals will be prepared in a metabolic kitchen housed in SBU's Business Incubator at Calverton. Meals will be prepared in batches, packaged and frozen at the incubator, then transported in a cooler with thermometers to the Food Service Department at SBU Hospital. Meals will be kept frozen in freezers until the day they are provided to participants. Logs of temperatures of coolers will be maintained daily, with temperatures checked every hour.

In order to provide meals, participants will come to the feeding site to eat breakfast onsite and pick up other meals and snacks for the rest of the day. Participants will be provided a closed envelope containing a form that will list their participant ID# and age in which they'll sign in and indicate if they've begun any new medications or been diagnosed with a disease since starting the study. Additionally, twice per week, participants will be weighed using a digital scale in order to track changes in body weight while on the study. If weight changes greater than 2% of baseline, calorie content of the meals will be modified to avoid further weight changes. Food for the rest of the day will be provided in an insulated bag containing frozen cold packs and participants will be instructed to keep lunch and dinner in the insulated bag or a refrigerator until eaten. They will be instructed to heat the respective meals in a microwave until hot, prior to consumption. They will be instructed to take a picture of each meal before and after eating and upload the pictures via a Qualtrics-based survey, in order for the investigators to estimate how much food has been eaten at each meal. Although participants will be instructed to only eat the food and beverages provided for the study, they will log any consumption of food or beverages not provided for the study via this same Qualtrics-based survey. Consumption of water, black coffee and tea will not be logged.

During days 7-9, 24-26 and 41-43 participants will provide a stool sample to be placed into a sterile container (provided by the study team) then placed into an opaque brown paper bag and provided to the study team. At the same time the stool sample is delivered, blood will be drawn to generate serum. If a participant provides samples in the earlier part of the collection period (e.g. day 7) they will proceed immediately to the next phase of the study.

Conditions
Diet, Healthy
Being tested
Dietary protein

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dietary proteinOther

    High protein followed by reduced protein diet

Study groups in NCT05377892
Study groupRoleWhat they receive
InterventionExperimentalSubjects receiving high protein followed by reduced protein diet
Receives: Other: Dietary protein

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subject reported adherence to study diet.

    Participants will take a picture of each meal before and after eating and upload the pictures via a Qualtrics-based survey. The investigators will use these images to estimate how much food has been eaten at each meal, then calculate macronutrient intake based on the nutrient content of each food item. Participants will log any consumption of food or beverages not provided for the study via this same Qualtrics-based survey in order to estimate the contribution of non-study foods to overall macronutrient consumption. The average percent change in protein intake across subjects after switching from acclimation to high protein or high protein to reduced protein stages will be quantified.

    Measured: 5 weeks

  2. Mass spectrometry-based measurement of abundance of metabolites in blood

    Global metabolite profiling will be carried out using mass spectrometry on blood collected at the end of the acclimation, high protein and reduced protein stages. Data will be log transformed and paired t tests will be conducted to determine if significant changes in abundance occur following consumption of high protein or reduced protein diets

    Measured: 4 weeks

  3. Mass spectrometry-based measurement of abundance of metabolites in stool

    Global metabolite profiling will be carried out using mass spectrometry on stool collected at the end of the acclimation, high protein and reduced protein stages. Data will be log transformed and paired t tests will be conducted to determine if significant changes in abundance occur following consumption of high protein or reduced protein diets

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2022
  2. Study start4 Nov 2019
  3. Primary completion5 Mar 2020
  4. Study completion5 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Sequential
Model description
Longitudinal
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05377892
Sponsor's protocol ID
IRB2019-00415
Status last verified
May 2022
First submitted
4 May 2022
Last updated
17 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: publication of results in scientific journal

Questions about this trial

What is this clinical trial studying?

A study testing Dietary protein in people with Diet, Healthy, run by Stony Brook University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subject reported adherence to study diet. (time frame: 5 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in